| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9270492 | Journal of Infection | 2005 | 8 Pages |
Abstract
Conclusions. Our result suggests that AGM and N-PCR can be used as markers for assessing the monitoring and the introduction pre-emptive therapy. This approach could prove to be more cost-effective than ganciclovir universal prophylaxis for treating CMV infection.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Sandra H.A. Bonon, Silvia M.F. Menoni, Cláudio L. Rossi, Cármino A. De Souza, Afonso C. Vigorito, Daniel B. Costa, Sandra C.B. Costa,